Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
NCT05209776Recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Feb 2022
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoints: C-reactive protein at 24 months, Interleukin-1 at 24 months and 4 more. Started Feb 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05209776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05209776.